Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.63% |
| 2 | Technology | 4.94% |
| 3 | Financials | 3.76% |
| 4 | Energy | 3.19% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LNW
3601
CALL
DELISTED
Light & Wonder
LNW
| $381K | ﹤0.01% |
+25,400
| New | +$360K |
|
3602
CALL
Masco
MAS
$15.3B
| $380K | ﹤0.01% |
16,615
-17,753
| -52% | -$420K |
|
|
QEP
3603
CALL
DELISTED
QEP RESOURCES, INC.
QEP
| $380K | ﹤0.01% |
21,100
-7,000
| -25% | -$144K |
|
|
CA
3604
PUT
DELISTED
CA, Inc.
CA
| $380K | ﹤0.01% |
13,100
+3,800
| +41% | +$118K |
|
3605
Anika Therapeutics
ANIK
$287M
| $378K | ﹤0.01% |
11,479
+11,044
| +2,539% | +$394K |
|
3606
PUT
Icahn Enterprises
IEP
$5.3B
| $378K | ﹤0.01% |
4,400
-12,300
| -74% | -$1.11M |
|
3607
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$310M
| $377K | ﹤0.01% |
12,559
+287
| +2% | +$8.97K |
|
|
CVC
3608
PUT
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $377K | ﹤0.01% |
16,400
+10,300
| +169% | +$224K |
|
3609
Steven Madden
SHOO
$3.55B
| $376K | ﹤0.01% |
13,449
+4,458
| +50% | +$118K |
|
3610
GoDaddy
GDDY
$11.5B
| $375K | ﹤0.01% |
+13,392
| New | +$363K |
|
|
PARAA
3611
DELISTED
Paramount Global Class A
PARAA
| $375K | ﹤0.01% |
6,588
+6,485
| +6,296% | +$414K |
|
|
CVSA
3612
PUT
Covista Inc
CVSA
$4.8B
| $374K | ﹤0.01% |
12,900
+5,700
| +79% | +$188K |
|
|
AMAG
3613
PUT
DELISTED
AMAG Pharmaceuticals
AMAG
| $373K | ﹤0.01% |
5,400
+3,200
| +145% | +$201K |
|
3614
CALL
BioCryst Pharmaceuticals
BCRX
$2.4B
| $372K | ﹤0.01% |
26,600
+500
| +2% | +$5.68K |
|
3615
CALL
C.H. Robinson
CHRW
$17.5B
| $372K | ﹤0.01% |
6,000
-40,700
| -87% | -$2.68M |
|
3616
PUT
Packaging Corp of America
PKG
$22.8B
| $372K | ﹤0.01% |
6,000
-1,600
| -21% | -$113K |
|
3617
CALL
Teradyne
TER
$59.3B
| $372K | ﹤0.01% |
19,600
-206,000
| -91% | -$4.12M |
|
3618
PUT
Ternium
TX
$10.6B
| $372K | ﹤0.01% |
21,900
+1,200
| +6% | +$23.6K |
|
3619
PUT
ProShares Ultra Financials
UYG
$847M
| $372K | ﹤0.01% |
15,300
-9,300
| -38% | -$232K |
|
|
PRE
3620
CALL
DELISTED
PARTNERRE LTD
PRE
| $371K | ﹤0.01% |
2,900
+2,500
| +625% | +$322K |
|
3621
PUT
Flowers Foods
FLO
$1.57B
| $370K | ﹤0.01% |
+17,600
| New | +$395K |
|
|
QVCGA
3622
PUT
DELISTED
QVC Group Inc Series A
QVCGA
| $370K | ﹤0.01% |
282
+204
| +262% | +$284K |
|
3623
PUT
ProShares Ultra Russell2000
UWM
$249M
| $369K | ﹤0.01% |
15,200
-10,000
| -40% | -$245K |
|
|
QTS
3624
DELISTED
QTS REALTY TRUST, INC.
QTS
| $369K | ﹤0.01% |
10,243
+9,545
| +1,367% | +$353K |
|
3625
CALL
Axos Financial
AX
$5.68B
| $368K | ﹤0.01% |
14,000
| – | – |
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays's Q2 2015 filing shows 425 new, 2,570 increased, 3,770 reduced and 450 closed positions. Its largest new stake was Element Solutions: 801,973 shares worth $20M. The largest sale was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7.6% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.